Journals / Anadolu Psikiyatri Dergisi / 2018 / Cilt: 19 - Sayı: 2

Serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-?, and IFN-? levels in drug- free, comorbidity-free obsessive-compulsive disorder patients

İlaç kullanmayan ve komorbiditesi olmayan obsesif kompulsif bozukluk hastalarında serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-? ve IFN-? düzeyler

Pages
157–162
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is important to continue investigating the role of cytokines and other immunological markers in both the etiology and treatment of OCD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Increasing evidence suggests that certain inflammatory factors, especially cytokines, can lead to neurochemical and behavioural changes via their role in the brain signalling system.
📊
Key Findings & Data:Studies investigating cytokine abnormalities in obsessive-compulsive disorder (OCD) have yielded conflicting results thus far.
💡
Conclusion & Impact:It is important to continue investigating the role of cytokines and other immunological markers in both the etiology and treatment of OCD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Increasing evidence suggests that certain inflammatory factors, especially cytokines, can lead to neurochemical and behavioural changes via their role in the brain signalling system. Studies investigating cytokine abnormalities in obsessive-compulsive disorder (OCD) have yielded conflicting results thus far. The aim of this study was to investigate the serum IL-1, IL-4, IL-6, IL-10, TNF-?, and IFN-? levels in drug-free, comorbidity-free patients with OCD. Methods: Forty comorbidity-free, drug-free OCD patients and 40 age- and sex-matched healthy volunteers were included in the study. Clinical severity was assessed using the Yale-Brown Obsessive-Compulsive Evaluation Scale (YBOCES). Results: IL-1 levels were significantly higher and IL-2, IL-6, and TNF-? levels were significantly lower in patients than in controls. No differences were observed in IL-4, IL-10, and IFN-? levels. However, a negative relationship was found between IL-1 levels and compulsive symptoms (YBOCES) in OCD patients. Conclusions: Our findings suggest the possible role of cytokines in the pathogenesis of OCD. It is important to continue investigating the role of cytokines and other immunological markers in both the etiology and treatment of OCD.

Özet

Amaç: Bazı inflamatuar etkenlerin beyin sinyalizasyon sistemindeki rolü bilinmektedir. Artan kanıtlar, bu inflamatuar etkenlerin en önemlileri olan sitokinlerin nörokimyasal ve davranışsal değişikliklere neden olabileceğini düşündürmektedir. Obsesif kompulsif bozukluktaki (OKB) sitokin anormalliklerini araştıran çalışmalar şimdiye kadar çelişkili sonuçlar vermiştir. Bu çalışmanın amacı, ilaçsız, komorbiditesi olmayan OKB hastalarında serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-? ve IFN-? düzeylerini araştırmaktır. Yöntem: Çalışmaya komorbiditesi olmayan ve ilaç kullanmayan 40 OKB hastası ile yaş ve cinsiyet açısından eşleştirilmiş 40 sağlıklı gönüllü alındı. Klinik şiddet Yale Brown Obsesyon Kompulsiyon Ölçeği (YBOKÖ) kullanılarak değerlendirildi. Bulgular: IL-1 düzeyleri hastalarda anlamlı olarak yüksekti. IL-2, IL-6 ve TNF-? düzeyleri ise hastalarda kontrollerden daha düşüktü. IL-4, IL-10 ve IFN-? düzeyleri için herhangi bir fark gözlemlenmedi. Bununla birlikte, OKB hastalarında IL-1 düzeyleri ile kompulsiyon (YBOKÖ) puanları arasında negatif korelasyon saptandı. Tartışma: Bulgularımız, OKB patogenezinde sitokinlerin olası rolünü ileri sürmektedir. Hem etiyoloji, hem de yeni tedavi hedefleri açısından OKB'de sitokinlerin ve diğer immunolojik belirteçlerin rolünü araştıracak ileri çalışmalara gerek vardır.

🔖

Cite This Article

ERBAYGÖNENİR, L., AKTI, N. K., TAŞKAPAN, M. Ç., INCE, L. U., YOLOĞLU, S., TEMELLİ, H. G., ÜNAL, S. (2018). Serum IL-1, IL-2, IL-4, IL-6, IL-10, TNF-?, and IFN-? levels in drug- free, comorbidity-free obsessive-compulsive disorder patients. Anadolu Psikiyatri Dergisi, Cilt: 19 - Sayı: 2, 157–162. https://ajindex.com/articles/355740

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Westenberg HG, Fineberg NA, Denys D. Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr 2007; 12:14-27
  2. Rotge JY, Aouizerate B, Tignol J, Bioulac B, Burbaud P, Guehl D. The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms. Neuroscience 2010; 165: 408-417
  3. Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology and treatment. Pharmacol Ther 2011; 132:314-332
  4. Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci 2014; 15:410-424
  5. Ciranna L. Serotonin as a modulator of glutamateand GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr Neuropharmacol 2006; 4:101-114
  6. Tseng KY, O'Donnell P. Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 2004; 24:5131-5139
  7. Lesch KP. When the serotonin transporter gene meets adversity: the contribution of animal models to understanding epigenetic mechanisms in affective disorders and resilience. Curr Top Behav Neurosci 2011; 7:251-280
  8. Murphy TK, Kurlan R, Leckman J. The immunebiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol 2010; 20:317-331
  9. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000; 157:683-694
  10. Nawa H, Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 2006; 56:2-13
  11. Rothwell NJ. Annual review prize lecture cytokines-killers in the brain? J Physiol 1999; 514:3- 17
  12. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008; 63:801-808
  13. Vitkovic L, Bockaert J, Jacque C. Inflammatory cytokines: neuromodulators in normal brain? J Neurochem 2000; 74:457-471
  14. Abbas AK, Lohr J, Knoechel B. Balancing autoaggressive and protective T cell responses. J Autoimmun 2007; 28:59-61
  15. Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 2005; 30:17